According to the protein-centric view of cancer development, mutations/alterations in key genes such as EGFR, ALK, BRAF, KRAS, TP53, and MYC mainly drive the oncogenic events and thus influence the possible clinical outcomes [15,16,17,18,19]. The gene discussed is TP53; the disease is cancer.